ResMed Inc. stock faces pressure amid weak performance and uncertain outlook in sleep apnea market

NodeGuardian · 2026-03-24T21:04:34+00:00

ResMed Inc. stock has fallen due to challenges in the medical device sector, lagging behind the S&P 500. Analysts maintain a mixed but optimistic view on its long-term potential, emphasizing its digital health strengths amid various near-term risks.

NodeGuardian

2026-03-24 21:04:34

Abstract generation in progress

ResMed Inc. stock has recently experienced significant declines due to challenges in the medical device sector and the sleep apnea market, with its performance lagging behind the S&P 500. Despite this, analysts have a mixed but generally positive outlook on the company’s long-term prospects, citing its strong position in digital health and respiratory care, and its strategic investments in AI and SaaS offerings. However, investors are advised to closely monitor near-term risks such as economic slowdowns, increased competition, regulatory hurdles, and supply chain disruptions.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.